Prelude Therapeutics (PRLD) Insider Trading & Ownership $0.68 -0.03 (-4.67%) Closing price 04:00 PM EasternExtended Trading$0.69 +0.01 (+1.78%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Prelude Therapeutics (NASDAQ:PRLD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage62.80%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$781,961.25Number OfInsiders Selling(Last 12 Months)0 Get PRLD Insider Trade Alerts Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PRLD Insider Buying and Selling by Quarter Remove Ads Prelude Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/25/2025Andrew CombsInsiderBuy100,000$0.69$69,000.00 3/25/2025Krishna VaddiCEOBuy675,000$0.69$465,750.00 3/12/2025Krishna VaddiCEOBuy47,500$0.71$33,725.00 12/30/2024Krishna VaddiCEOBuy10,000$1.20$12,000.00 12/23/2024Andrew CombsInsiderBuy60,000$1.37$82,200.00 12/20/2024Andrew CombsInsiderBuy3,075$1.15$3,536.25 12/19/2024Bryant David LimCFOBuy25,000$0.91$22,750.00 12/18/2024Krishna VaddiCEOBuy100,000$0.93$93,000.00 (Data available from 1/1/2013 forward) PRLD Insider Trading Activity - Frequently Asked Questions Who is on Prelude Therapeutics's Insider Roster? The list of insiders at Prelude Therapeutics includes Andrew Combs, Bryant David Lim, Jane Huang, Krishna Vaddi, Laurent Chardonnet, and Orbimed Advisors Llc. Learn more on insiders at PRLD. What percentage of Prelude Therapeutics stock is owned by insiders? 62.80% of Prelude Therapeutics stock is owned by insiders. Learn more on PRLD's insider holdings. Which Prelude Therapeutics insiders have been buying company stock? The following insiders have purchased PRLD shares in the last 24 months: Andrew Combs ($154,736.25), Bryant David Lim ($22,750.00), Krishna Vaddi ($609,485.00), and Orbimed Advisors Llc ($4,999,998.75). How much insider buying is happening at Prelude Therapeutics? Insiders have purchased a total of 1,891,140 PRLD shares in the last 24 months for a total of $5,786,970.00 bought. Which Prelude Therapeutics insiders have been selling company stock? The following insider sold PRLD shares in the last 24 months: Jane Huang ($81,273.60). How much insider selling is happening at Prelude Therapeutics? Insiders have sold a total of 13,280 Prelude Therapeutics shares in the last 24 months for a total of $81,273.60 sold. Prelude Therapeutics Key ExecutivesDr. Krishna Vaddi D.V.M. (Age 58)Ph.D., Founder, CEO & Director Compensation: $905.92kDr. Edna Huang M.D. (Age 51)President & Chief Medical Officer Compensation: $865.63kMr. Bryant David Lim J.D. (Age 53)Interim CFO, Chief Legal Officer & Corporate Secretary Compensation: $586.42k1 recent tradesMs. Aimee Crombie Ph.D.Senior VP and Head of Strategic Planning & OperationsDr. Madhu Pudipeddi Ph.D.Senior Vice President of Technical OperationsDr. Peggy A. Scherle Ph.D. (Age 62)Chief Scientific Officer Compensation: $868.62kLindsey TrickettVice President of Investor RelationsMs. Michele Porreca M.B.A.Chief People OfficerDr. Andrew P. Combs Ph.D. (Age 57)Executive VP & Chief Chemistry Officer Compensation: $562.46kMr. Naveen Babbar Ph.D.Senior Vice President of Translation Medicine More Insider Trading Tools from MarketBeat Related Companies Aclaris Therapeutics Insider Trades Korro Bio Insider Trades Neumora Therapeutics Insider Trades DiaMedica Therapeutics Insider Trades RAPT Therapeutics Insider Trades Aardvark Therapeutics Insider Trades Lyell Immunopharma Insider Trades Fulcrum Therapeutics Insider Trades Protara Therapeutics Insider Trades Inhibikase Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:PRLD) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
